Fig. 4From: CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancerCombination therapy of anti-CD25 and anti-TGF-β improves clinical outcomes in PDAC murine models. a Schema of tumor implantation and treatment with anti-CD25 and anti-TGF-β. b Tumor growth curves of mice implanted with Panc02 tumor cells and administrated with anti-CD25 and/or anti-TGF-βBack to article page